Status:
UNKNOWN
Walking and Blood Pressure in Older Adults With Respiratory Impairment.
Lead Sponsor:
Iowa State University
Conditions:
Respiratory Impairment
Elevated Blood Pressure
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effect of an 8-week walking program on blood pressure in inactive older adults with respiratory impairment, a condition where lung function is sub-optimal ...
Detailed Description
Older adults are particularly susceptible to respiratory impairment (a condition of lung dysfunction) due in part to longer lifetime exposures to air pollutants, tobacco smoke, and physical inactivity...
Eligibility Criteria
Inclusion
- Men and women aged 65 years and above.
- Elevated systolic blood pressure (120mmHg - 159 mmHg), and/or individuals taking medications for high blood pressure with a systolic pressure less than or equal to 159mmHg.
- Respiratory impairment as assessed by abnormal spirometry (a lung function test). Abnormal spirometric phenotypes include obstructive pattern, restrictive pattern, mixed obstructive/restrictive, and preserved ratio impaired spirometry (PRISm).
- Non-smoker (defined as being tobacco-free for at least the previous 12-months).
- Body mass index (BMI) \<42kg/m2.
- Physically inactive (determined by a 7-day day assessment of step counts using a pedometer, and defined as having an average daily step count \<7,000).
- Willingness to increase daily steps.
Exclusion
- History of stroke, heart attack, or cancer diagnosis in the last 6-months.
- Admission to hospital for a respiratory-related illness (e.g., COPD exacerbation, pneumonia, lung injury, etc.) within the last 3 months.
- The use of supplemental oxygen.
- Neurological conditions such as Alzheimer's or Parkinson's disease.
- Significant mobility limitation (e.g., severe arthritis) that would hinder the ability to increase daily steps.
- The use of a cane or walker.
- Participants engaged in another walking study or structured walking program.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06033417
Start Date
September 1 2023
End Date
May 1 2024
Last Update
September 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Iowa State University
Ames, Iowa, United States, 50011